Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Veru Inc. - Common Stock
(NQ:
VERU
)
2.640
+0.220 (+9.09%)
Streaming Delayed Price
Updated: 3:13 PM EST, Jan 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Veru Inc. - Common Stock
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
VERU ALERT: Bragar Eagel & Squire, P.C. is Investigating Veru Inc. on Behalf of Veru Stockholders and Encourages Investors to Contact the Firm
November 14, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
Why Veru Stock Was Losing One-Third of Its Value This Week
↗
November 11, 2022
The future of a top pipeline drug now looks much dimmer.
Via
The Motley Fool
INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Veru Inc. and Encourages Investors with Losses to Contact the Firm
November 11, 2022
From
The Schall Law Firm
Via
Business Wire
Dow Jumps Over 1,000 Points; Digital Turbine Shares Spike Higher
↗
November 10, 2022
U.S. stocks traded sharply higher toward the end of trading, with the NASDAQ Composite jumping over 6% on Thursday.
Via
Benzinga
Why Veru Stock Is Cratering Today
↗
November 10, 2022
A negative vote on one of its drugs is weighing on the biotech's stock price.
Via
The Motley Fool
Why Is VERU Stock Down 50% Today?
↗
November 10, 2022
The regulatory hammer is hitting VERU stock investors hard today as the FDA denies a crucial authorization for Veru's Covid-19 drug.
Via
InvestorPlace
Why Veru Stock Is Skyrocketing Today
↗
November 07, 2022
Investors are reacting positively to an FDA briefing document.
Via
The Motley Fool
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
↗
November 11, 2022
Gainers
Via
Benzinga
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Veru Inc. and Encourages Investors with Losses to Contact the Firm
November 10, 2022
From
The Schall Law Firm
Via
Business Wire
Why Magnite Shares Are Trading Higher By Over 45%? Here Are 69 Stocks Moving In Thursday's Mid-Day Session
↗
November 10, 2022
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares climbed 172% to $0.2769 after dipping 40% on Wednesday. Fast Radius received Bankruptcy court approval of first day motions related to the company's...
Via
Benzinga
Oracle Layoffs 2022: What to Know About ORCL Job Cuts, Hiring Freeze
↗
November 10, 2022
Oracle (ORCL) layoffs are worth checking out on Thursday as investors keep track of tech companies that are cutting employees.
Via
InvestorPlace
Dow Soars Over 900 Points; Nasdaq Over 600
↗
November 10, 2022
Inflation data for October is sending stocks to the moon today.
Via
Talk Markets
Nasdaq Surges 600 Points; Gold Gains 2%
↗
November 10, 2022
U.S. stocks traded sharply higher midway through trading , with the Nasdaq Composite gaining 600 points on Thursday.
Via
Benzinga
Cano Health, Vacasa, Organogenesis, And Some Other Big Stocks Moving Lower On Thursday
↗
November 10, 2022
U.S. stocks traded higher, with the Nasdaq surging more than 500 points on Thursday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Dow Jumps Over 700 Points; US Inflation Rate Falls In October
↗
November 10, 2022
U.S. stocks traded sharply higher this morning , following the release of inflation data on Thursday.
Via
Benzinga
Veru Stock Plummets 65% After FDA Advisors Vote Down Cancer-Turned-Covid Drug
↗
November 10, 2022
The FDA isn't bound by the advisors' recommendation. But it does consider their vote.
Via
Investor's Business Daily
How Is The Market Feeling About Veru?
↗
November 10, 2022
Veru's (NASDAQ:VERU) short percent of float has fallen 12.12% since its last report. The company recently reported that it has 14.69 million shares sold short, which is 22.76% of all regular shares...
Via
Benzinga
Veru Stock Could Retrace Week's 45% Gain As FDA Panel Votes Against COVID-19 Drug
↗
November 10, 2022
Veru Inc.
Via
Benzinga
Spirit AeroSystems, Oyster Point Pharma, Snap And Other Big Gainers From Monday
↗
November 08, 2022
U.S. stocks closed higher on Monday, with the Dow Jones surging more than 400 points. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
VERU Stock Soars 40% Despite Uncertainty Surrounding Covid-19 Drug
↗
November 07, 2022
While the FDA may have some questions regarding Veru’s Covid-19 therapeutic, investors remain optimistic about VERU stock.
Via
InvestorPlace
Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday
↗
November 08, 2022
Gainers
Via
Benzinga
Dow Surges 400 Points; Crude Oil Down 1%
↗
November 07, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 400 points on Monday.
Via
Benzinga
Medical Leader Veru Catapults As FDA Preps To Discuss Cancer Drug For Covid
↗
November 07, 2022
The company's drug could be used in a specific population of Covid patients.
Via
Investor's Business Daily
Veru Shares Jump Over 40% Despite FDA Staff Raises Uncertainties Over Its COVID-19 Therapy
↗
November 07, 2022
Veru Inc (NASDAQ: VERU) is set to face an FDA Advisory Committee meeting on Wednesday regarding its emergency use authorization (EUA) application for the oral COVID-19 therapy sabizabulin.
Via
Benzinga
Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session
↗
November 07, 2022
Gainers Dragon Victory International Limited (NASDAQ: LYL) surged 52.2% to $0.6870.
Via
Benzinga
$100 Invested In Veru 5 Years Ago Would Be Worth This Much Today
↗
November 07, 2022
Veru (NASDAQ:VERU) has outperformed the market over the past 5 years by 56.49% on an annualized basis producing an average annual return of 64.35%. Currently, Veru has a market capitalization of $1.22...
Via
Benzinga
Dow Jumps Over 200 Points; Verve Therapeutics Shares Plummet
↗
November 07, 2022
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 200 points on Monday.
Via
Benzinga
US Stocks Mixed; Dow Rises Over 50 Points
↗
November 07, 2022
U.S. stocks traded mixed this morning, with the Dow Jones gaining over 50 points on Monday.
Via
Benzinga
Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know
↗
November 01, 2022
October proved to be a mixed month for the Food and Drug Administration’s regulatory decisions. Two new molecular entities, or NMEs, were approved during the month, bringing the tally for the...
Via
Benzinga
Jim Cramer Says People Are Betting Against Stock Up 84% This Year: It Could Be An 'Up Big, Down Big Situation'
↗
October 18, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he can’t recommend Dice Therapeutics Inc (NASDAQ: DICE) as the company is "losing money hand over fist."
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
